Literature DB >> 16040065

Hippocampal dopamine receptors modulate cFos expression in the rat nucleus accumbens evoked by chemical stimulation of the ventral hippocampus.

Teodoro Zornoza1, María J Cano-Cebrián, Fernando Martínez-García, Ana Polache, Luis Granero.   

Abstract

Recently, we have shown that D1 and D2 receptors in the ventral hippocampus (VH) modulate both the locomotor activation and the increase in dopamine (DA) levels in the rat nucleus accumbens (NAc) induced by NMDA stimulation of the VH. In the present study we analyze the possible role of VH D1 and D2 receptors in the modulation of the cFos expression in NAc (core and shell subregions) and in dorsal striatum. This was assessed by immunohistochemical analysis of cFos expression in the rat brains after retro-dialysis application of NMDA (50mM, 10 min) into VH, in absence and in presence of either the D1/D5 receptor antagonist SCH 23390 (100 and 250 microM, 60 min) or the D2 receptor antagonist raclopride (100 and 250 microM, 60 min). NMDA induced a robust increase in the cFos expression in the NAc shell, both in the ipsilateral and contralateral side. No statistically significant increases were observed in the NAc core and in the dorsal striatum. Simultaneous application of SCH 23390 and NMDA into the VH attenuated the NMDA-evoked cFos expression in NAc shell. In contrast, raclopride had no significant effect. Our present results show that the NMDA receptor mediated effects in the VH require D1 receptors and suggest that DA in VH strongly modulates the excitatory outputs from this brain area.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16040065     DOI: 10.1016/j.neuropharm.2005.06.005

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  7 in total

Review 1.  Adult Neurogenesis and Psychiatric Disorders.

Authors:  Eunchai Kang; Zhexing Wen; Hongjun Song; Kimberly M Christian; Guo-Li Ming
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

2.  Repeated cocaine enhances ventral hippocampal-stimulated dopamine efflux in the nucleus accumbens and alters ventral hippocampal NMDA receptor subunit expression.

Authors:  Jeffrey L Barr; Gina L Forster; Ellen M Unterwald
Journal:  J Neurochem       Date:  2014-06-23       Impact factor: 5.372

3.  Epigenetic Regulation of Hippocampal Fosb Expression Controls Behavioral Responses to Cocaine.

Authors:  Paula A Gajewski; Andrew L Eagle; Elizabeth S Williams; Claire E Manning; Haley Lynch; Colin McCornack; Ian Maze; Elizabeth A Heller; A J Robison
Journal:  J Neurosci       Date:  2019-09-02       Impact factor: 6.167

4.  Brain Activation by Peptide Pro-Leu-Gly-NH(2) (MIF-1).

Authors:  Reas S Khan; Chuanhui Yu; Abba J Kastin; Yi He; Rudolph H Ehrensing; Hung Hsuchou; Kirsten Prufer Stone; Weihong Pan
Journal:  Int J Pept       Date:  2010-03-28

5.  Local hippocampal methamphetamine-induced reinforcement.

Authors:  Ulises M Ricoy; Joe L Martinez
Journal:  Front Behav Neurosci       Date:  2009-11-16       Impact factor: 3.558

6.  The Effects of N-Acetylcysteine on the Rat Mesocorticolimbic Pathway: Role of mGluR5 Receptors and Interaction with Ethanol.

Authors:  Sandra Fernández-Rodríguez; Claudia Esposito-Zapero; Teodoro Zornoza; Ana Polache; Luis Granero; María José Cano-Cebrián
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-20

7.  Sp1 expression is disrupted in schizophrenia; a possible mechanism for the abnormal expression of mitochondrial complex I genes, NDUFV1 and NDUFV2.

Authors:  Dorit Ben-Shachar; Rachel Karry
Journal:  PLoS One       Date:  2007-09-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.